1. Home
  2. OCS vs CNOB Comparison

OCS vs CNOB Comparison

Compare OCS & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • CNOB
  • Stock Information
  • Founded
  • OCS 2003
  • CNOB 1982
  • Country
  • OCS Switzerland
  • CNOB United States
  • Employees
  • OCS N/A
  • CNOB N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • CNOB Major Banks
  • Sector
  • OCS Health Care
  • CNOB Finance
  • Exchange
  • OCS Nasdaq
  • CNOB Nasdaq
  • Market Cap
  • OCS 1.0B
  • CNOB 1.2B
  • IPO Year
  • OCS N/A
  • CNOB 1996
  • Fundamental
  • Price
  • OCS $19.00
  • CNOB $25.01
  • Analyst Decision
  • OCS Strong Buy
  • CNOB Buy
  • Analyst Count
  • OCS 3
  • CNOB 2
  • Target Price
  • OCS $35.33
  • CNOB $28.00
  • AVG Volume (30 Days)
  • OCS 27.1K
  • CNOB 315.6K
  • Earning Date
  • OCS 08-26-2025
  • CNOB 07-24-2025
  • Dividend Yield
  • OCS N/A
  • CNOB 2.88%
  • EPS Growth
  • OCS N/A
  • CNOB N/A
  • EPS
  • OCS N/A
  • CNOB 1.84
  • Revenue
  • OCS $847,333.00
  • CNOB $256,824,000.00
  • Revenue This Year
  • OCS $18.70
  • CNOB $45.61
  • Revenue Next Year
  • OCS $1,059.78
  • CNOB $30.74
  • P/E Ratio
  • OCS N/A
  • CNOB $13.59
  • Revenue Growth
  • OCS N/A
  • CNOB 1.84
  • 52 Week Low
  • OCS $10.79
  • CNOB $17.98
  • 52 Week High
  • OCS $23.08
  • CNOB $29.31
  • Technical
  • Relative Strength Index (RSI)
  • OCS 46.89
  • CNOB 68.35
  • Support Level
  • OCS $18.87
  • CNOB $23.04
  • Resistance Level
  • OCS $19.75
  • CNOB $23.33
  • Average True Range (ATR)
  • OCS 0.43
  • CNOB 0.67
  • MACD
  • OCS -0.11
  • CNOB 0.28
  • Stochastic Oscillator
  • OCS 32.43
  • CNOB 94.43

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About CNOB ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.

Share on Social Networks: